Statistical methods for evaluating delirium in the ICU

The Lancet Respiratory Medicine

Volumn 4, Issue 7, 2016, Pages 534-536

  Colantuoni, Elizabeth ^a,b   Dinglas, Victor D ^a,c   Ely, E Wesley ^d,e   Hopkins, Ramona O ^f,g,h   Needham, Dale M ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f INTERMOUNTAIN MEDICAL CENTER   (United States)

^g BRIGHAM YOUNG UNIVERSITY   (United States)

^h INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE BRAIN DISEASE; CRITICALLY ILL PATIENT; DELIRIUM; DISEASE DURATION; DISEASE SEVERITY; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MATHEMATICAL ANALYSIS; METHODOLOGY; MORTALITY; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

DELIRIUM; HUMANS; INTENSIVE CARE UNITS;

EID: 84971595405     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)30138-2     Document Type: Note

References (10)

1. 1 Needham, DM, Colantuoni, E, Dinglas, VD, et al. Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial. Lancet Respir Med 4 (2016), 203–212.
2. 2 Billings, FT IV, Hendricks, PA, Schildcrout, JS, et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA 315 (2016), 877–888.
3. 3 Simons, KS, Laheijj, RJF, van den Boogaard, M, et al. Dynamic light application therapy to reduce the incidence and duration of delirium in intensive-care patients: a randomised controlled trial. Lancet Respir Med 4 (2016), 194–202.
4. 4 Casarin, A, McAuley, DF, Alce, TM, et al. Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled. Trials, 16, 2016, 218.
5. 5 Sharshar, T, Polito, A, Bozza, F, et al. Statins and brain dysfunction in intensive care. Lancet Respir Med 4 (2016), 169–170.
6. 6 Schoenfeld, DA, Bernard, GR, ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 30 (2002), 1772–1777.
7. 7 Rondeau, V, Mathoulin-Pellissier, S, Jacqmin-Gadda, H, et al. Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events. Biostatistics 8 (2007), 708–721.
8. 8 Rondeau, V, Mazroui, Y, Gonzalez, JR, Frailtypack: an R package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametric estimation. J Stat Soft 47 (2012), 1–28.
9. 9 Fan, E, Shahid, S, Kondreddi, VP, et al. Informed consent in the critically ill: a two-step approach incorporating delirium screening. Crit Care Med 36 (2008), 94–99.
10. 10 Neufeld, K, Hayat, MJ, Coughlin, JM, et al. Evaluation of two intensive care delirium screening tools for non-critically ill hospitalized patients. Psychosomatics 52 (2011), 133–140.